Invention Publication
- Patent Title: COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
-
Application No.: US18169964Application Date: 2023-02-16
-
Publication No.: US20230192757A1Publication Date: 2023-06-22
- Inventor: Gabriel Martinez Botella , Francesco G. Salituro , Albert Jean Robichaud , Boyd L. Harrison
- Applicant: Sage Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Sage Therapeutics, Inc.
- Current Assignee: Sage Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Main IPC: C07J43/00
- IPC: C07J43/00 ; C07D249/18 ; C07D231/14 ; C07D295/033 ; C07D249/04 ; A61P25/00 ; C07J13/00 ; C07J75/00 ; A61K9/00 ; A61K31/58

Abstract:
Described herein are neuroactive steroids of the Formula (I): or a pharmaceutically acceptable salt thereof; wherein, R1, R2a, R2b, R3 and A are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.
Public/Granted literature
- US12180248B2 Compositions and methods for treating CNS disorders Public/Granted day:2024-12-31
Information query